trending Market Intelligence /marketintelligence/en/news-insights/trending/jd0IQ-XDJgBZePSZaYCKGg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Eleven Biotherapeutics receives Nasdaq noncompliance notice

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Eleven Biotherapeutics receives Nasdaq noncompliance notice

Eleven Biotherapeutics Inc. received a notice from the Nasdaq Stock Market LLC for failing to meet the $1 minimum bid price listing requirement.

The company has 180 days or until June 11, 2018, to regain compliance.

To regain compliance, the closing bid price of the company's common stock must meet or exceed $1 per share for a minimum of 10 consecutive business days during the 180-day period.